Literature DB >> 10653058

Osteoporosis: epidemiology, diagnosis, and treatment.

M M Iqbal1.   

Abstract

Osteoporosis is an important health problem in the United States affecting approximately 24 million Americans, 15 to 20 million of whom are women over 45 years of age. Bone fractures are the major cause of morbidity and mortality associated with osteoporosis. The most common fractures are those of the forearm, hip, and vertebral body, as well as the humerus, tibia, pelvis, and ribs. Osteoporosis-related injuries result in complications leading to prolonged hospitalization, decreased independence, increased incidence of depression, and a reduced quality of life. The disease takes an enormous personal and economic toll, with estimated costs in excess of $13.8 billion annually for direct medical treatment. The incidence of osteoporosis-related fractures is increasing and constitutes a major public health problem in the United States. With a few preventive measures such as identification of risk factors, careful examination, and a few simple diagnostic tests, prevention of osteoporosis during the teen and early adult years is far superior to any treatment for older individuals. Osteoporosis can be identified and an appropriate treatment strategy can be determined.

Entities:  

Mesh:

Year:  2000        PMID: 10653058     DOI: 10.1097/00007611-200093010-00002

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  23 in total

Review 1.  Metabolic bone disease in IBD.

Authors:  I Lopez; A L Buchman
Journal:  Curr Gastroenterol Rep       Date:  2000-08

Review 2.  Alendronate: an update of its use in osteoporosis.

Authors:  M Sharpe; S Noble; C M Spencer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling.

Authors:  Xiangwei Wu; Lijuan Pang; Weiqi Lei; William Lu; Jun Li; Zhaoyang Li; Frank J Frassica; Xueling Chen; Mei Wan; Xu Cao
Journal:  Cell Stem Cell       Date:  2010-11-05       Impact factor: 24.633

4.  Mechanical evaluation of fourth-generation composite femur hybrid locking plate constructs.

Authors:  Tarun Goswami; Vinit Patel; David J Dalstrom; Michael J Prayson
Journal:  J Mater Sci Mater Med       Date:  2011-07-17       Impact factor: 3.896

5.  A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking.

Authors:  Biao Wang; Hua Guo; Li Yuan; Dageng Huang; Haiping Zhang; Dingjun Hao
Journal:  Eur Spine J       Date:  2016-02-05       Impact factor: 3.134

Review 6.  The impact of osteoporosis prevention programs on calcium intake: a systematic review.

Authors:  P Ryan; A Schlidt; C Ryan
Journal:  Osteoporos Int       Date:  2013-01-12       Impact factor: 4.507

Review 7.  HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?

Authors:  Raymond G Schlienger; Christoph R Meier
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans.

Authors:  Folasade Ojo; Soham Al Snih; Laura A Ray; Mukaila A Raji; Kyriakos S Markides
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

9.  Profound muscle weakness and pain after one dose of actonel.

Authors:  Irina Badayan; Merit E Cudkowicz
Journal:  Case Rep Med       Date:  2009-10-11

10.  Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy.

Authors:  Mir Sadat-Ali; Abdulmohsen H Alelq; Badar A Alshafei; Haifa A Al-Turki; Mohammed A Abujubara
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.